Showing 221 - 240 results of 464 for search '"Multiple Sclerosis"', query time: 0.10s Refine Results
  1. 221

    Telerehabilitation applications could solve the barriers of meaningful rehabilitee pathways in early stage of Multiple Sclerosis – A case study by Sanna Laine, Heidi Leinonen, Hilkka Korpi, Tuulikki Sjögren

    Published 2024-12-01
    “… Multiple Sclerosis (MS) is a neurological disease affecting particularly the working age population. …”
    Get full text
    Article
  2. 222

    Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis by Rosa F. Lara Rodríguez, Roman Rodríguez, Alicia Vargas Batista, Miriam Bolet Arostavista, Rebeca A. Fernández Carriera, Idalmis Suárez Luis, Alina González-Quevedo Monteagudo, Lorenzo Gómez Morales

    Published 2007-05-01
    “…Corticotropin is a steroid which is also used in the treatment of multiple sclerosis. <strong>Objetives:</strong> To compare the adverse effects of the biomodulina and corticotroprin in the treatment of multiple sclerosis. …”
    Get full text
    Article
  3. 223

    Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up by Riwanti Estiasari, Adisresti Diwyacitta, Muhammad Sidik, Ni Nengah Rida Ariarini, Freddy Sitorus, Saraf Shafa Marwadhani, Kartika Maharani, Darma Imran, Reza Aditya Arpandy, David Pangeran, Manfaluthy Hakim

    Published 2021-01-01
    “…Background. Multiple sclerosis (MS) is an autoimmune disease characterized by inflammation and demyelination of the central nervous system which often involves the optic nerve even though only 20% of the patients experience optic neuritis (ON). …”
    Get full text
    Article
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229
  10. 230

    Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population by Dingwei Dai, Ajay Sharma, Amy L. Phillips, Carroline Lobo

    Published 2022-11-01
    “…**Background:** Comorbidities are common in patients with multiple sclerosis (MS), thus increasing the complexity of disease management and economic burden and worsening their prognosis and quality of life. …”
    Get full text
    Article
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238

    Topographical mapping of metabolic abnormalities in multiple sclerosis using rapid echo-less 3D-MR spectroscopic imaging at 7T by Eva Niess, Assunta Dal-Bianco, Bernhard Strasser, Fabian Niess, Lukas Hingerl, Beata Bachrata, Stanislav Motyka, Paulus Rommer, Siegfried Trattnig, Wolfgang Bogner

    Published 2025-03-01
    “…Objectives: To assess topographical patterns of metabolic abnormalities in the cerebrum of multiple sclerosis (MS) patients and their relationship to clinical disability using rapid echo-less 3D-MR spectroscopic imaging (MRSI) at 7T. …”
    Get full text
    Article
  19. 239

    Anatomical Covariance Analysis: Detection of Disrupted Correlation Network Related to Clinical Trait Fatigue in Multiple Sclerosis: A Pilot Study by Rosalia Dacosta-Aguayo, Glenn Wylie, John DeLuca, Helen Genova

    Published 2020-01-01
    “…Fatigue is one of the most distressing symptoms among persons with multiple sclerosis (PwMS). The experience of fatigue is inherently interoceptive, yet no study to date has explicitly investigated the insular cortex (IC) as a primary goal in the experience of fatigue in PwMS. …”
    Get full text
    Article
  20. 240

    Motor Sequence Learning across Multiple Sessions Is Not Facilitated by Targeting Consolidation with Posttraining tDCS in Patients with Progressive Multiple Sclerosis by Harald Seelmann-Eggebert, Muriel Stoppe, Florian Then Bergh, Joseph Classen, Jost-Julian Rumpf

    Published 2021-01-01
    “…Compared to relapsing-remitting multiple sclerosis (MS), progressive MS is characterized by a lack of spontaneous recovery and a poor response to pharmaceutical immunomodulatory treatment. …”
    Get full text
    Article